Teladoc Health, Inc. (NYSE:TDOC – Get Free Report) insider Arnnon Geshuri sold 7,500 shares of the stock in a transaction on Monday, March 25th. The shares were sold at an average price of $15.06, for a total transaction of $112,950.00. Following the completion of the sale, the insider now directly owns 38,470 shares in the company, valued at approximately $579,358.20. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.
Teladoc Health Stock Up 1.5 %
NYSE:TDOC opened at $15.27 on Thursday. Teladoc Health, Inc. has a fifty-two week low of $14.29 and a fifty-two week high of $30.41. The company has a debt-to-equity ratio of 0.66, a quick ratio of 3.47 and a current ratio of 3.54. The company’s 50-day simple moving average is $17.60 and its 200-day simple moving average is $18.60.
Teladoc Health (NYSE:TDOC – Get Free Report) last released its quarterly earnings results on Tuesday, February 20th. The health services provider reported ($0.17) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.22) by $0.05. The business had revenue of $660.50 million for the quarter, compared to analysts’ expectations of $670.79 million. Teladoc Health had a negative net margin of 8.47% and a negative return on equity of 9.22%. The company’s revenue was up 3.6% compared to the same quarter last year. During the same period last year, the business earned ($0.23) EPS. On average, equities analysts forecast that Teladoc Health, Inc. will post -1.07 EPS for the current year.
Institutional Trading of Teladoc Health
Wall Street Analyst Weigh In
Several research analysts recently commented on TDOC shares. Citigroup reduced their price target on shares of Teladoc Health from $21.00 to $19.00 and set a “neutral” rating on the stock in a research note on Wednesday, February 21st. Cantor Fitzgerald started coverage on shares of Teladoc Health in a research note on Thursday, February 29th. They issued an “overweight” rating and a $22.00 price target on the stock. Piper Sandler reduced their price target on shares of Teladoc Health from $30.00 to $25.00 and set an “overweight” rating on the stock in a research note on Wednesday, February 21st. Canaccord Genuity Group reduced their price target on shares of Teladoc Health from $34.00 to $28.00 and set a “buy” rating on the stock in a research note on Wednesday, February 21st. Finally, Truist Financial dropped their target price on shares of Teladoc Health from $23.00 to $17.00 and set a “hold” rating on the stock in a report on Wednesday, March 6th. Eight research analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to MarketBeat, Teladoc Health currently has an average rating of “Hold” and a consensus target price of $22.43.
Read Our Latest Stock Report on TDOC
Teladoc Health Company Profile
Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.
Further Reading
- Five stocks we like better than Teladoc Health
- How to Calculate Return on Investment (ROI)
- Best Bear Market Funds: Top 3 Investment Options to Consider
- The Significance of Brokerage Rankings in Stock Selection
- Is DraftKings A Good Bet Ahead of Q1 Earnings?
- Find and Profitably Trade Stocks at 52-Week Lows
- Mid-Cap Stocks to Outperform the Market This Cycle
Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.